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Effect of parturition and recombination bovine somatotropin (rBST) on the
metabolic profile of dairy cows
Abstract
Summary Blood samples were collected from 16 Holstein cows around parturition to obtain baseline
values of various hormones and metabolites. At 90 ± 3 days postcalving, cows were divided into two
groups (8 cows/group) and injected with either saline (control) or 25 mg rBST/d for 28 consecutive days.
Blood was sampled on days 0, 1, 5, 10, 15, 30, and 45 after the beginning of treatment and analyzed for
insulin, glucagon, growth hormone, glucose, and blood urea nitrogen (BUN). Milk production and
composition were recorded as well as body weights and condition scores. Cows receiving rBST had
higher milk yields than control cows during the treatment period. Milk lactose percentage also increased
for cows on rBST, but other milk components remained unchanged. Plasma insulin decreased, and
glucagon, growth hormone, glucose, and BUN increased from 10 days prepartum to 10 days postpartum.
During the treatment period, insulin and glucagon decreased slightly for the rBST group, growth hormone
increased for both rBST and control groups, and glucose and BUN were similar between rBST and control
groups. Body weights and body condition scores decreased after parturition but remained unchanged
during the injection period.; Dairy Day, 1990, Kansas State University, Manhattan, KS, 1990; The 1990
Annual KSU Dairy Day is known as Dairy Day, 1990
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EFFECT OF PARTURITION AND RECOMBINANT BOVINE
SOMATOTROPIN (rBST) ON THE METABOLIC
PROFILE OF DAIRY COWS
J. M. Estrada and J. E. Shirley

Summary
Blood samples were collected from 16 Holstein cows around parturition to obtain baseline
values of various hormones and metabolites. At 90 ± 3 days postcalving, cows were divided into two
groups (8 cows/group) and injected with either saline (control) or 25 mg rBST/d for 28 consecutive
days. Blood was sampled on days 0, 1, 5, 10, 15, 30, and 45 after the beginning of treatment and
analyzed for insulin, glucagon, growth hormone, glucose, and blood urea nitrogen (BUN). Milk
production and composition were recorded as well as body weights and condition scores. Cows
receiving rBST had higher milk yields than control cows during the treatment period. Milk lactose
percentage also increased for cows on rBST, but other milk components remained unchanged. Plasma
insulin decreased, and glucagon, growth hormone, glucose, and BUN increased from 10 days
prepartum to 10 days postpartum. During the treatment period, insulin and glucagon decreased slightly
for the rBST group, growth hormone increased for both rBST and control groups, and glucose and
BUN were similar between rBST and control groups. Body weights and body condition scores
decreased after parturition but remained unchanged during the injection period.
Introduction
The ability of somatotropin or growth hormone to stimulate milk production has been known
since 1937. With the development of recombinant technologies (biotechnology), substantial amounts
of somatotropin are available for large-scale use in dairy cattle. Recombinant bovine somatotropin
(rBST) increases milk production in dairy cows by shifting nutrient flow away from body fat stores to
meet the needs of the mammary gland for increased milk production. Parturition and initiation of
lactation are associated with metabolic and hormonal changes that redirect nutrients required for milk
production. Potential use of rBST in commercial dairy herds demands a full understanding of the
metabolic and hormonal changes that occur during treatment. The objectives of the present study were:
1) to determine if selected metabolic and hormonal changes normally associated with parturition and
initiation of lactation are similar during treatment with rBST and 2) to determine the effect of rBST
treatment on milk production and composition, body weight, and body condition score of dairy cows.
Procedures
Blood samples were collected from 16 Holstein cows (8 primiparous and 8 multiparous) on
5, 10, and 15 days before projected calving date, and on days 5, 10, 15, 30, 60, 75, and 82 postcalving
to obtain baseline values of various hormones and metabolites. Body weights and condition during
early lactation were also noted. Cows were paired at 90 days postcalving according to milk production,
days in milk, and milk fat percentage and allotted randomly to two treatment groups: saline (control)
or 25 mg rBST/day. Cows were injected for 28 consecutive days, and blood samples were taken at 0,
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1, 5, 10, 15, 30, and 45 days after the beginning of treatment. Blood plasma was analyzed for insulin,
glucagon, growth hormone, glucose, and blood urea nitrogen (BUN).
Milk yields were recorded daily. Milk composition was analyzed every 3 wk from the
beginning of lactation until 90 days postcalving and weekly during the rBST treatment period for milk
fat, protein, lactose, and solids non-fat (SNF) percent and for somatic cell counts (SCC). Cows were
group-fed twice daily a total mixed ration (TMR) consisting of 50% concentrate mix, 25% corn silage,
and 25% alfalfa hay, to meet NRC requirements. Water was available ad libitum. Body weight and
body condition score (scale 1 to 5; 1 = extremely thin, 5 = excessively fat) were recorded during every
blood sampling and weekly during the injection period.
Results and Discussion
Milk Production and Composition
Four percent fat- corrected milk
(FCM) yield showed a typical lactation
curve until 90 days postpartum. Fatcorrected milk yield increased (P<.01)
for cows on rBST when compared to
control cows (33.2 vs 28.4 kg/day).
Cows on rBST treament also maintained
higher persistency
of production
through 1 wk after treatment was
terminated (Figure 1). Milk lactose
percentage increased (P<.05) during the
treatment period for rBST compared to
the control group. Fat, protein, and
solids non-fat (SNF) percentages Figure 1. Milk production for control and rBST
remained unchanged during the treated cows (4% FCM).
injection period. Somatic cell counts
(SCC) appeared to be lower for the rBST group than for the control group, but differences were not
significant (Figure 2).
Hormone and Metabolic Traits
Insulin concentration in plasma decreased significantly from 10 days prepartum to 5 days
postpartum, as expected, and then increased (P<.01) to prepartum levels by day 30 of lactation. In
contrast, glucagon concentration increased 2.5 times from day 5 prepartum to day 10 postpartum
(P<.05; Figure 3) and then decreased by 50% by day 30 postpartum.
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Figure 2. Somatic cell count for control and
rBST during treatment period.

Figure 3. Concentrations of plasma insulin
and glucagon periparturient and in early
lactation.

Plasma insulin and glucagon (see Figure 3) stabilized at about the same concentration after 60
days postpartum. Plasma insulin and glucagon appeared to decrease for the rBST group compared to
the control group (Figure 4). Insulin to glucagon ratios were similar for rBST and control groups
during the injection period. Plasma growth hormone (GH) increased abruptly between 10 and 5 days
prepartum and continued to increase through day 5 postpartum (Figure 5). Growth hormone declined
to prepartum levels by day 15 postpartum. Growth hormone increased from day 1 to about day 15 of
treatment for both rBST and control groups, and there was no difference between groups. Growth
hormone was not increased for the rBST group because blood was sampled between 20 and 24 hours
after injection.

Figure 4. Concentrations of plasma insulin and
glucagon during rBST treatment.
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Figure 5. Concentrations of plasma
growth hormone periparturient and
during rBST treatment.

Plasma glucose concentration decreased slightly at parturition, then increased (P<.05) from
day 5 postpartum to day 30 postpartum, reflecting the increase in dry matter intake observed. Glucose
concentration remained stable from day 30 to day 90. No significant difference was noted between the
control and rBST groups relative to plasma glucose concentration (Figure 6). Blood urea nitrogen
(BUN) increased (P<.05) from day 5 prepartum to day 30 postpartum, reflecting the increase in protein
intake that follows parturition. No significant BUN changes occurred during the treatment period for
rBST or control groups (Figure 7).
Body Measurements
Body weight appeared to decrease from day 5 prepartum to day 15 postpartum, and then
increased slowly during the first part of lactation. Body condition scores decreased (P=.06) from day
5 prepartum to day 30 postpartum and increased thereafter. No significant changes were found
between control and rBST groups for body weights or body condition scores during the injection
period.

Figure 6. Plasma glucose levels periparturient
and during rBST treatment.

Figure 7. Blood urea nitrogen levels
periparturient and during rBST
treatment.

Conclusions
Periparturient data indicate the dramatic metabolic changes that occur during parturition and
the onset of lactation to accomodate the needs of milk production by shifting from an anabolic to a
catabolic state. As illustrated, milk production increased during supplementation with rBST, but these
data suggest that the metabolic changes that occur during rBST treatment are not as pronounced as
those occurring around parturition. Cows on rBST treatment were able to maintain body weight and
body condition score during the injection period. Adequate nutrient supplementation will allow cows
to maintain body weight when treated with rBST under the conditions of this study. Full response to
rBST will require competent nutritional, reproductive, health, and overall management. Additional
information on the mode of action of rBST will be important in determining management systems for
commercial dairy herds.
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